ReviewTherapeutic advances in hematology2016

Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib.

Jeff Sharman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.